New Key Statistics Module, Z-Score and F-Score
OTCPK:EMMA Key Ratios
Market Cap $ M | 5.36 |
Enterprise Value $ M | 38.77 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.21 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 28.00 |
EPS (TTM) $ | -0.09 |
Beneish M-Score | -1.67 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 19.39 |
EV-to-EBITDA | 19.02 |
PEG | -- |
Shares Outstanding M | 53.64 |
Net Margin (%) | -16.66 |
Operating Margin % | 2.70 |
Pre-tax Margin (%) | -16.42 |
Quick Ratio | 0.12 |
Current Ratio | 0.15 |
ROA % (ttm) | -10.00 |
ROE % (ttm) | -- |
ROIC % (ttm) | 0.96 |
Dividend Yield % | -- |
Altman Z-Score | -8.12 |
EMMA Number of Guru Trades
EMMA Volume of Guru Trades
Gurus Latest Trades with OTCPK:EMMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:EMMA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Emmaus Life Sciences Inc Insider Transactions
No Available Data
News about OTCPK:EMMA
Total 0- 1